60 Degrees Pharmaceuticals (SXTP) EBT (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly EBT of -$2.1 million for Q1 2026, down 11.34% year-over-year from -$2.4 million in Q1 2025, and down 113.0% quarter-over-quarter from -$981310.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) EBT (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported EBT for 5 consecutive years, with -$2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 11.34% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$7.1 million (up 30.59% YoY), while the FY2025 annual figure was -$6.9 million, up 13.16% from the prior year.
- EBT retreated to -$2.1 million in Q1 2026 per SXTP's latest filing, from -$981310.0 in the prior quarter.
- Across five years, EBT topped out at $4.2 million in Q3 2023 and bottomed at -$4.2 million in Q2 2024.
- Historically, EBT has averaged -$1.6 million across 5 years, with a median of -$2.0 million in 2023.
- Annual changes were most pronounced in 2023 — EBT soared 387.75% — and 2025, when it plunged 538.57%.
- 60 Degrees Pharmaceuticals' EBT stood at -$1.7 million in 2022, then declined by 22.53% to -$2.0 million in 2023, then slipped by 0.17% to -$2.0 million in 2024, then surged by 52.12% to -$981310.0 in 2025, then slumped by 113.0% to -$2.1 million in 2026.
- Business Quant data shows SXTP's EBT at -$2.1 million in Q1 2026, -$981310.0 in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 | -2.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.09 Mn |
| Dec 31, 2025 | -981,310.00 |
| Sep 30, 2025 | -2.32 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Dec 31, 2024 | -2.05 Mn |
| Sep 30, 2024 | -2.16 Mn |
| Jun 30, 2024 | -4.17 Mn |
| Mar 31, 2024 | 428,048.00 |
| Dec 31, 2023 | -2.05 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | -3.34 Mn |
| Mar 31, 2023 | -2.60 Mn |
| Dec 31, 2022 | -1.67 Mn |
| Sep 30, 2022 | -1.45 Mn |
| Jun 30, 2022 | -2.15 Mn |